Retatrutide (24 mg)

What is Retatrutide (24 mg)?

Retatrutide (24mg) is a synthetic investigational peptide studied in metabolic and cellular signaling research. It belongs to a class of engineered peptide analogs designed to interact with pathways involved in energy balance and metabolic regulation. Retatrutide is derived from hormone-related peptide frameworks and has been examined for its effects on metabolic signaling processes. From a chemical perspective, Retatrutide consists of exactly 39 amino acids, with a molecular weight of 4731.33 g/mol. It includes structural modifications such as lipid conjugation and C-terminal amidation, which may influence peptide stability and protein binding in experimental systems. Research-grade preparations typically report purity levels greater than 95–99%, verified by analytical testing.

What are the key features of Retatrutide (24 mg)?

• Chemical Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• Molecular Weight: 4731.33 g/mol
• CAS Number: 2381089-83-2
• Purity: typically ≥95–99%, verified by analytical testing
• Supplied as 24 mg lyophilized peptide in sealed vials
• Structural modifications: fatty acid conjugation and C-terminal amidation
• Intended for laboratory investigation of metabolic signaling pathways
• For research use only

How is Retatrutide (24 mg) synthesized?

Retatrutide is produced by synthetic peptide synthesis using solid-phase peptide synthesis (SPPS). This method allows researchers to assemble the peptide sequence step-by-step using protected amino acids, ensuring precise control over the final structure. After synthesis, the peptide is purified, often by high-performance liquid chromatography (HPLC), to achieve high purity. Mass spectrometry (MS) confirms the peptide’s molecular weight and structural integrity. The peptide is then lyophilized to maintain stability during storage and transportation.

What is Retatrutide (24 mg) being studied for? What are its possible benefits?

Retatrutide has been studied in various areas of metabolic and physiological research. Laboratory investigations focus on how peptide analogs can modulate signaling pathways involved in metabolism, energy balance, and cellular regulation. Research areas involving Retatrutide include:

• Metabolic pathway regulation
• Energy balance and nutrient signaling
• Hormone-related peptide signaling systems
• Cellular energy utilization
• Metabolic adaptation in experimental models

In research settings, these pathways are examined to better understand how complex signaling networks influence biological processes. However, these findings remain part of an ongoing investigation, and reported observations should not be interpreted as proven clinical outcomes.

How does Retatrutide (24 mg) work in research studies?

In laboratory studies, Retatrutide is investigated for its potential to modulate biological signaling pathways involved in metabolism and energy regulation. These systems involve peptide-based signaling molecules that coordinate communication between cells and tissues. Researchers examine how modified peptides like Retatrutide interact with metabolic pathways that regulate nutrient use, energy expenditure, and hormonal signaling. Structural features such as fatty acid conjugation and sequence modifications may help extend the peptide’s stability and allow it to remain active longer in experimental environments. By studying these mechanisms in controlled settings, scientists aim to understand how peptide signaling contributes to broader physiological processes.

What dosing information exists for Retatrutide (24 mg)?

Available dosing information primarily comes from experimental and preclinical studies rather than standardized laboratory protocols. In controlled research settings, peptide concentrations are often selected based on the study objectives and biological models under examination. Some studies involving related investigational peptides have explored dose ranges administered at periodic intervals in experimental models. These investigations aim to evaluate pharmacokinetics, metabolism, and signaling responses under controlled conditions. Note: No universally accepted human dosing guidelines exist for Retatrutide. Experimental concentrations used in laboratory research should be determined according to the study design, model system, and institutional research protocols.

How should Retatrutide (24 mg) be stored and handled?

• Store under temperature-controlled conditions per laboratory protocol and certificate of analysis.
• For extended storage, follow temperature conditions specified in the product certificate of analysis.
• Protect the lyophilized powder from light, heat, and moisture.
• Room-temperature exposure during transport is acceptable for short periods.
• Once reconstituted, store under appropriate temperature-controlled conditions per laboratory protocol for short-term use.
• Avoid repeated freeze-thaw cycles to preserve peptide integrity.
• Refer to the batch certificate of analysis for batch-specific stability data.

Where can I read more research about Retatrutide (24 mg)?

1. Coskun T, Urva S, Roell WC, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022;34(9):1234-1247.e9. doi:10.1016/j.cmet.2022.07.013
2. Ma J, Hu X, Zhang W, Tao M, Wang M, Lu W. Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice. Endocrine. 2025;87(1):159-169. doi:10.1007/s12020-024-03998-8
3. Finan B, Ma T, Ottaway N, et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med. 2013;5(209):209ra151. doi:10.1126/scitranslmed.3007218
4. Willard FS, Douros JD, Gabe MB, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020;5(17):e140532. Published 2020 Sep 3. doi:10.1172/jci.insight.140532
5. National Center for Biotechnology Information. PubChem Compound Summary for CID 171390338, Retatrutide. https://pubchem.ncbi.nlm.nih.gov/compound/Retatrutide

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.